Results 201 to 210 of about 145,206 (314)
Explainable machine learning for predicting postoperative length of stay after gastrectomy: a nationwide study using XGBoost and SHAP. [PDF]
Maruyama T +5 more
europepmc +1 more source
Migration of Fish Bones to the Bile Duct Following Hepaticojejunostomy
ABSTRACT Objectives Migration of fish bones into the bile duct is rare, but can cause bile duct stone formation or acute cholangitis. Herein, we examine the characteristics of this phenomenon. Methods This single‐center, retrospective study enrolled patients with a history of fish bone extraction from the bile duct by an endoscopic procedure at our ...
Kenta Yoshida +11 more
wiley +1 more source
Subtotal versus total gastrectomy for mid- and distal gastric poorly cohesive carcinoma: a retrospective controlled study. [PDF]
Dinçer B +6 more
europepmc +1 more source
What's New? Patients with esophageal or gastroesophageal junction (GEJ) cancer with residual disease after treatment with neoadjuvant chemoradiotherapy (nCRT) and resection frequently experience poor survival. Improvements in outcome, however, may be possible using adjuvant treatment with nivolumab.
Rob H. A. Verhoeven +9 more
wiley +1 more source
Laparoscopic sleeve gastrectomy in a patient with type 1 diabetes and kidney transplant: A case report. [PDF]
Ayora-Pérez MJ +6 more
europepmc +1 more source
ABSTRACT Advances in hepatology—such as noninvasive serum biomarkers (e.g., Fibrosure since 2004), imaging techniques (e.g., MR Elastography since 2009 and FibroScan since 2013), and effective direct‐acting antivirals for the treatment of chronic hepatitis C—have likely influenced liver biopsy practices.
Nazire E. Albayrak +8 more
wiley +1 more source
Infrapyloric Lymph Node Dissection Technique in Robotic Gastrectomy With Recognition of the Embryological Fusion Plane. [PDF]
Yamana I +4 more
europepmc +1 more source
Natural Products in Cancer Prevention and Therapy: Current Challenges and Future Directions
Natural products play a pivotal role in cancer therapy. They induce cancer cell death by reprogramming four metabolic pathways while precisely targeting the tumor microenvironment and immune cells. These compounds not only leverage novel delivery systems for innovative applications but also demonstrate unique therapeutic efficacy across clinical stages:
Ruimiao Qian +8 more
wiley +1 more source

